Professional
Added to YB: 2022-12-15
Pitch date: 2022-12-15
MDGL [bullish]
Madrigal Pharmaceuticals, Inc.
+599.66%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
Market Cap
$10.6B
Pitch Price
$62.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
-32.07
P/E
-35.65
EV/Sales
13.22
Sector
Biotechnology
Category
N/A
Show full summary:
L1 Capital Long Short - Q4 Letter: Madrigal Pharmaceuticals
A summary for this pitch has not been created yet.
Read full article (1 min)